EOE 13 en es it fr

EOE 13 Brand names, EOE 13 Analogs

EOE 13 Brand Names Mixture

  • No information avaliable

EOE 13 Chemical_Formula


EOE 13 RX_link

No information avaliable

EOE 13 fda sheet

EOE 13 msds (material safety sheet)

EOE 13 Synthesis Reference

No information avaliable

EOE 13 Molecular Weight

354.483 g/mol

EOE 13 Melting Point

No information avaliable

EOE 13 H2O Solubility

No information avaliable

EOE 13 State


EOE 13 LogP


EOE 13 Dosage Forms


EOE 13 Indication

For the treatment of severe psoriasis in adults.

EOE 13 Pharmacology

The active metabolite responsible for etretinate's effects, acitretin, is a retinoid. Retinoids have a structure similar to vitamin A and are involved in the normal growth of skin cells. Acitretin works by inhibiting the excessive cell growth and keratinisation (process by which skin cells become thickened due to the deposition of a protein within them) seen in psoriasis. It therefore reduces the thickening of the skin, plaque formation and scaling.

EOE 13 Absorption

Absorbed in the small intestine. Studies in normal volunteers indicate that the absorption of etretinate is greater in patients consuming whole milk or a high-fat diet than in patients in a fasting state.

EOE 13 side effects and Toxicity

Symptoms of overdose include headache and vertigo.

EOE 13 Patient Information

EOE 13 Organisms Affected

Humans and other mammals